Addex Therapeutics Ltd (SWX:ADXN)
Switzerland · Delayed Price · Currency is CHF 0.0420
+0.0014 (3.45%)
Jul 31, 2026, 5:30 PM CET
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of 5.01 million as of July 31, 2026. Its market cap has decreased by -11.53% in one year.
Market Cap
5.01M
Enterprise Value
4.18M
Revenue
109.50K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
ChartMarket Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from 398.65M to 5.01M, a decrease of -98.74%. That is a compound annual growth rate of -20.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 5.01M | -22.40% |
| Dec 30, 2025 | 6.46M | 14.83% |
| Dec 30, 2024 | 5.62M | -9.01% |
| Dec 29, 2023 | 6.18M | -40.48% |
| Dec 30, 2022 | 10.39M | -73.65% |
| Dec 30, 2021 | 39.42M | -25.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.61B |
| Idorsia | 1.56B |
| Basilea Pharmaceutica AG | 643.35M |
| Newron Pharmaceuticals | 242.60M |
| Santhera Pharmaceuticals Holding AG | 212.07M |
| BioVersys AG | 155.73M |
| Molecular Partners AG | 124.91M |
| Xlife Sciences AG | 96.94M |